c8alpha
Investors / stance tracking

What Dan Skelly is saying

Head of Market Research & Strategy, Morgan Stanley Wealth Management

5 dated public stances tracked since 2026-09-04, most recently 2026-09-04. Each line carries the date and the venue it came from; quotation marks mean verbatim. Methodology.

The stances below are c8alpha's editorial distillation of Dan Skelly's public commentary — television, podcasts, and interviews — compiled by automated transcript analysis and dated to the episode they came from. They may lag the speaker's current view and may contain extraction errors. Text in quotation marks is verbatim from the episode; everything else is our paraphrase. Dan Skelly is not affiliated with c8alpha and has not endorsed this page. Nothing here is investment advice.

Think we got something wrong? Report a misattribution — we correct it or take it down.

5
tracked stances
5
themes
0
side flips
2026-09-04
last heard

Most-argued themes

ThemeStancesLeanMixLast
Big Tech11 bullish2026-09-04
HEALTHCARE SECTOR11 bullish2026-09-04
NDAQ11 bullish2026-09-04
SMALL-CAP EQUITIES (RUSSELL 2000)11 bearish2026-09-04
SPGI11 bullish2026-09-04

Tracked stances

bullish / bearish is a view they argued; owns / short is a position they said they hold.

2026-09-04 SMALL-CAP EQUITIES (RUSSELL 2000) bearish The Compound · video
Small caps face dual AI risk — disintermediation from AI in industries where they lack capital to defend, and inability to capture AI adoption upside — compounded by rates sensitivity for the 40%-unprofitable lower-quality Russell cohort.
“AI could be really tricky for small caps — they might have a left tail risk disintermediation and a right tail risk in terms of not participating in the AI adoption”
How to Pick Stocks Like Morgan Stanley | TCAF 258
2026-09-04 SPGI bullish The Compound · video
Market priced SPGI's data business for AI obsolescence, but the issuance business is a direct beneficiary of record debt financing volumes and the regulated data business has durable moats that AI cannot displace.
“bond investors need ratings. They don't — they're not going to take Claude's word for it. Regulated.”
How to Pick Stocks Like Morgan Stanley | TCAF 258
2026-09-04 NDAQ bullish The Compound · video
Nasdaq Inc. was swept into the February AI-data-obsolescence selloff but its regulated crown-jewel data business, capital markets tailwind from the coming IPO wave, and AI utilization within its own platform are not reflected in a flat multiple against…
“we're saying there's this whole wave of AI disruptors coming along and NASDAQ's not going to capture its share of that upside. It makes no sense.”
How to Pick Stocks Like Morgan Stanley | TCAF 258
2026-09-04 HEALTHCARE SECTOR bullish The Compound · video
AI is compressing Phase 1 drug discovery timelines from six-to-seven years to under twelve months, and downstream life-science tools, consumables, and CROs are beneficiaries, while the sector underperformed for years due to COVID comps, rate cycle, and growth…
“AI in many instances is taking a six to seven-year timeline in terms of phase one drug discovery to like less than 12 months”
How to Pick Stocks Like Morgan Stanley | TCAF 258
2026-09-04 Big Tech bullish The Compound · video
2027 could mirror 2023 with monolithic Mag 7 outperformance as average companies struggle to comp the synthetic tariff-driven operating leverage tailwind, while the largest AI-enablers continue to dominate in cloud, robotics, autonomous, and quantum.
“27 could look a lot like 23 where it's a return of more monolithic Mag 7 outperformance”
How to Pick Stocks Like Morgan Stanley | TCAF 258

Idea Scout Weekly

Every Sunday: who said what across the tape we track — 1766 voices, 5,177 episodes and articles — with side-flips and points of disagreement called out. Free. How we track it.

Free · double opt-in · unsubscribe in one click

Follow an investor and their newest stances lead The Brief, the free morning email; these pages update every morning.